Company profile: JSS Medical Research
1.1 - Company Overview
Company description
- Provider of full-service clinical research organization (CRO) with strong academic affiliations, offering services internationally, including management of Phase I-III clinical trials; design and execution of late and post-approval studies; market access and HEOR (budget impact analysis, cost-effectiveness models); regulatory and clinical development consulting; biostatistics; and medical writing.
Products and services
- Market Access & HEOR: Delivers model-based health economics and outcomes research services, performing budget impact analysis and constructing cost-effectiveness models across international engagements
- Clinical Trials: Architects and runs full-service Phase I–III programs, covering study planning, execution, and proactive clinical program management with international reach across trial operations
- Post-Approval Studies: Engineers late-phase, post-approval investigations, designing and executing studies specifically to meet defined post-approval objectives, delivered internationally
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to JSS Medical Research
Liverpool ChiroChem
HQ: United Kingdom
Website
- Description: Provider of chiral small molecules for biotech/pharma R&D, offering specialist building blocks, fragments and screening compounds to enable small molecule drug discovery, plus ultra-large (1.4B), covalent (800k) and kinase-focused (4.5M) virtual libraries, DEL synthons, heterobifunctional linkers, and a parallel synthesis lab producing up to 5,000 compounds per month.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liverpool ChiroChem company profile →
Nanopharm
HQ: United Kingdom
Website
- Description: Provider of science-driven orally inhaled and nasal drug product design and development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanopharm company profile →
Nutra-Med Packaging
HQ: United States
Website
- Description: Provider of supply chain management and contract packaging for pharmaceutical and healthcare products, offering blister packaging (thermoforming, cold forming, barcode printing), high-speed bottling (glass vials/bottles, labeling, gummy vitamins, serialization/aggregation), secondary assembly and kitting, cartoning, serialization for bottles, blisters and cartons, and cold chain storage with 80 pallet locations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutra-Med Packaging company profile →
KBI Biopharma
HQ: United States
Website
- Description: Provider of fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally; a leading development and contract manufacturing organization serving the biopharmaceutical industry, working closely with client partners to personalize and rapidly accelerate drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KBI Biopharma company profile →
Biofer
HQ: Italy
Website
- Description: Provider of organic and inorganic medicinal chemicals and active pharmaceutical ingredients, including iron complexes for anemia, heparins and glycosaminoglycans as antithrombotics to prevent blood clots, steroids for anti-shock and antiallergic uses, folinates as antitumor adjuvants supporting cancer therapies, and enzymes as anti-inflammatories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biofer company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for JSS Medical Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to JSS Medical Research
2.2 - Growth funds investing in similar companies to JSS Medical Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for JSS Medical Research
4.2 - Public trading comparable groups for JSS Medical Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →